Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sean X Cavanaugh

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Nature Biotechnology|June 4, 2004
An image worth a thousand lives?Lisa A Hammond, Sean X Cavanaugh, Charles R Thomas
Urology|March 23, 2005
Applying complexed prostate-specific antigen to clinical practiceTodd J Scarbrough, Sean X Cavanaugh, Charles R Thomas
Oral Oncology|April 6, 2004
In vivo dose perturbation effects of metallic dental alloys during head and neck irradiation with intensity modulated radiation therapyClifton D Fuller, Irma Diaz, Sean X Cavanaugh, et al.
Technology in Cancer Research & Treatment|April 12, 2003
Daily stereotactic ultrasound prostate targeting: inter-user variabilityMartin Fuss, Sean X Cavanaugh, Cristina Fuss, et al.
Nursing Administration Quarterly|August 29, 2023
Radiation Oncologist Shortage Creates Opportunity for NPsSusan L Swanson, John W Swanson, Sean X Cavanaugh, et al.
Technology in Cancer Research & Treatment|January 31, 2004
Repositioning accuracy of a commercially available double-vacuum whole body immobilization system for stereotactic body radiation therapyMartin Fuss, Bill J Salter, Premavathy Rassiah, et al.
International Journal of Radiation Oncology, Biology, Physics|April 20, 2004
Significant rectal and bladder dose reduction via utilization of Foley balloon catheters in high-dose-rate tandem and ovoid intracavitary brachytherapy of the uterine cervixTony Y Eng, Clifton D Fuller, Sean X Cavanaugh, et al.
Cancer|June 29, 2004
Early prostate-specific antigen (PSA) kinetics following prostate carcinoma radiotherapy: prognostic value of a time-and-PSA threshold modelSean X Cavanaugh, Patrick A Kupelian, Clifton D Fuller, et al.
American Journal of Clinical Oncology|December 15, 2004
Treatment of merkel cell carcinomaTony Y Eng, Melisa G K Boersma, Clifton D Fuller, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 15, 2006
Image-guided intensity-modulated radiation therapy for gallbladder carcinomaClifton D Fuller, Charles R Thomas, Adrian Wong, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Nature Biotechnology|June 4, 2004
An image worth a thousand lives?Lisa A Hammond, Sean X Cavanaugh, Charles R Thomas
Urology|March 23, 2005
Applying complexed prostate-specific antigen to clinical practiceTodd J Scarbrough, Sean X Cavanaugh, Charles R Thomas
Oral Oncology|April 6, 2004
In vivo dose perturbation effects of metallic dental alloys during head and neck irradiation with intensity modulated radiation therapyClifton D Fuller, Irma Diaz, Sean X Cavanaugh, et al.
Technology in Cancer Research & Treatment|April 12, 2003
Daily stereotactic ultrasound prostate targeting: inter-user variabilityMartin Fuss, Sean X Cavanaugh, Cristina Fuss, et al.
Nursing Administration Quarterly|August 29, 2023
Radiation Oncologist Shortage Creates Opportunity for NPsSusan L Swanson, John W Swanson, Sean X Cavanaugh, et al.
Technology in Cancer Research & Treatment|January 31, 2004
Repositioning accuracy of a commercially available double-vacuum whole body immobilization system for stereotactic body radiation therapyMartin Fuss, Bill J Salter, Premavathy Rassiah, et al.
International Journal of Radiation Oncology, Biology, Physics|April 20, 2004
Significant rectal and bladder dose reduction via utilization of Foley balloon catheters in high-dose-rate tandem and ovoid intracavitary brachytherapy of the uterine cervixTony Y Eng, Clifton D Fuller, Sean X Cavanaugh, et al.
Cancer|June 29, 2004
Early prostate-specific antigen (PSA) kinetics following prostate carcinoma radiotherapy: prognostic value of a time-and-PSA threshold modelSean X Cavanaugh, Patrick A Kupelian, Clifton D Fuller, et al.
American Journal of Clinical Oncology|December 15, 2004
Treatment of merkel cell carcinomaTony Y Eng, Melisa G K Boersma, Clifton D Fuller, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 15, 2006
Image-guided intensity-modulated radiation therapy for gallbladder carcinomaClifton D Fuller, Charles R Thomas, Adrian Wong, et al.
Pageof 2